The Medicines and Healthcare Regulatory Authority (MHRA) held a tender to entrust the development of a system based on artificial intelligence.
ADR
How to manage the pharmacological risk in the elderly
Adverse drug reactions (ADR) are common in the elderly and manifest themselves with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding. In the latest issue of the journal Pro Terza Età di ANASTE an article of mine has been published that illustrates how to manage this serious risk.
Amazon Alexa now provides information about drugs
Amazon announced yesterday that, thanks to an agreement with First Databank (FDB), Alexa is able to provide consumers with a wide variety of drug information. Continue reading
How much does the security of care weigh in the choices of IT investments?
Information technology can play a key role in improving the safety of care. Yet, despite this, patient safety solutions have low priority over IT investments. Continue reading
Why it is worthwhile to invest in CDSS: the pharmacological risk
Adverse drug reactions (ADRs) are a serious public health issue, being a major cause of morbidity and mortality. Clinical Decision Support Systems (CDSS) can reduce this phenomenon and the associated costs. Continue reading
Digital-health 